1[1]Guengerich FP. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol,2001,14:611
2[2]Yun CH, Okerholm RA, Guengerich FP. Oxidation of the antihistamine drug terfenadine in human liver microsomes: role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos,1993,21:403
3[3]Beaune P, Dansette PM, Mansuy D,et al. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci USA,1987,84:551
4[4]Trauner M, Meier PJ, Boyer J. Molecular pathogenesis of cholestasis. N Engl J Med,1998,339:1217
5[5]Robin M-A, Le Roy M, Descatoire V,et al. Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatol,1997,26:Suppl 1:23
6[6]Reed JC. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med,2001,7:314
7[7]Pessayre D, Berson A, Fromenty B,et al. Mitochondria in steatohepatitis. Semin Liver Dis,2001,21:57
8[8]Jonsson JR, Edwards-Smith CJ, Catania SC,et al. Expression of cytokines and factors modulating apoptosis by human sinusoidal lymphocytes. J Hepatol,2000,32:392
